Changes in protein levels associated with EMT were observed, including increase of N-cadherin (N-cad) (“cadherin switch”), and decreases of E-cadherin (E-cad), tumor markers vimentin (VM) and fibronectin (FN) (Supplementary Figure S1A). The gene discussed is CDH17; the disease is neoplasm.